Humanigen Inc (HGENQ)
0.0002
-0.01
(-97.01%)
USD |
OTCM |
Apr 26, 16:00
Humanigen Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2016 | 0.103M |
| September 30, 2016 | 0.649M |
| June 30, 2016 | 7.588M |
| March 31, 2016 | 18.23M |
| December 31, 2015 | 30.10M |
| September 30, 2015 | 37.34M |
| June 30, 2015 | 42.34M |
| March 31, 2015 | 12.56M |
| December 31, 2014 | -8.22M |
| Date | Value |
|---|---|
| September 30, 2014 | -6.972M |
| June 30, 2014 | -6.793M |
| March 31, 2014 | -25.08M |
| December 31, 2013 | -13.92M |
| September 30, 2013 | -14.09M |
| June 30, 2013 | -26.96M |
| March 31, 2013 | 2.78M |
| December 31, 2012 | 5.075M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Athersys Inc | 1.968M |
| Merck & Co Inc | -14.08B |
| MEI Pharma Inc | 58.90M |
| ContraFect Corp | 12.80M |
| Bristol-Myers Squibb Co | -21.70B |